simvastatin has been researched along with Congestive Ophthalmopathy in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Liao, SL; Tang, WC; Wang, CC; Wang, SH; Wei, YH; Yang, CH | 1 |
| Liao, SL; Wang, CC; Wang, SH; Wei, YH; Yang, CH | 1 |
| Beck-Peccoz, P; Campi, I; Covelli, D; Currò, N; D'Ambrosio, R; Gianelli, U; Maggioni, M; Salvi, M; Vannucchi, G | 1 |
3 other study(ies) available for simvastatin and Congestive Ophthalmopathy
| Article | Year |
|---|---|
Simvastatin Inhibits CYR61 Expression in Orbital Fibroblasts in Graves' Ophthalmopathy through the Regulation of FoxO3a Signaling.
Topics: Adult; Chemokine CCL20; Cysteine-Rich Protein 61; Eye; Female; Fibroblasts; Forkhead Box Protein O3; Gene Expression Regulation; Graves Ophthalmopathy; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Interleukin-6; Male; Middle Aged; Signal Transduction; Simvastatin | 2021 |
Simvastatin and ROCK Inhibitor Y-27632 Inhibit Myofibroblast Differentiation of Graves' Ophthalmopathy-Derived Orbital Fibroblasts
Topics: Adult; Amides; Cell Differentiation; Female; Fibrosis; Graves Ophthalmopathy; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; MAP Kinase Signaling System; Middle Aged; Myofibroblasts; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Primary Cell Culture; Pyridines; rho-Associated Kinases; rhoA GTP-Binding Protein; Simvastatin; Transforming Growth Factor beta | 2020 |
Statins may increase the risk of liver dysfunction in patients treated with steroids for active graves' orbitopathy.
Topics: Chemical and Drug Induced Liver Injury; Female; Glucocorticoids; Graves Ophthalmopathy; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Methylprednisolone; Middle Aged; Simvastatin | 2015 |